Dr. S. Leigh Verbois Named Chief Executive Officer of Rx-360

FDA Alum to Lead Rx-360's Next Chapter of Global Quality and Patient Safety Collaboration

PHILADELPHIA, July 14, 2026 /PRNewswire/ -- Rx-360 is pleased to announce the appointment of Dr. S. Leigh Verbois as Chief Executive Officer – effective July 14, 2026 – marking a significant milestone in our continued commitment to protecting patient safety by advancing global pharmaceutical supply chain security and quality.

"I am thrilled to take on this role during this dynamic time in the pharmaceutical industry. l eagerly await working with the talented Rx-360 team to protect patients through global collaboration across the pharmaceutical sector through optimization of existing capabilities and innovation in global supply chain security and integrity," said Verbois.